EUVIMEDOtkrijte EUVIMED
Leserbrief

Preliminary outcome of Chelidonium majus (greater celandine) for COVID ‐19

Nilo E Gardin iD, Anne Jacqueline Braga

Phytotherapy Research · 2024

DOI: 10.1002/ptr.7776 ↗

At a glance

Leserbrief in Phytotherapy Research, 2024. Written by Nilo E Gardin and 1 co-authors. Institution: Brazilian Association of Anthroposophic Medicine, São Paulo, Brazil. Major MEDLINE topics: COVID-19, Chelidonium. 3 references.

SažetakSubjectsBibliografski podaciCiteRelated studies

Abstract (original language)

Sažetak nije dostupan.

Subjects

MeSH terms (MEDLINE)

COVID-19ChelidoniumHumansChelidonium majus

Authors and institutions

  • Brazilian Association of Anthroposophic Medicine, São Paulo, Brazil.
  • Brazilian Association of Anthroposophic Medicine, Aracaju, Brazil.

ORCID profiles: Nilo E Gardin

Cite

APA

Gardin, N. E., & Braga, A. J. (2024). Preliminary outcome of Chelidonium majus (greater celandine) for COVID ‐19. Phytotherapy Research. https://doi.org/10.1002/ptr.7776

Vancouver

Gardin NE, Braga AJ. Preliminary outcome of Chelidonium majus (greater celandine) for COVID ‐19. Phytotherapy Research. 2024. doi:10.1002/ptr.7776

BibTeX
@article{Gardin2024,
  author = {Gardin, Nilo E and Braga, Anne Jacqueline},
  title = {Preliminary outcome of Chelidonium majus (greater celandine) for COVID ‐19},
  journal = {Phytotherapy Research},
  year = {2024},
  doi = {10.1002/ptr.7776}
}
Start for free →